tiprankstipranks
Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market
AMLX
Amylyx Pharmaceuticals Inc
RESEARCH TOOLSreports
Want to see AMLX full AI Analyst Report?

Amylyx Pharmaceuticals Inc (AMLX) Financial Statements

659 Followers

Amylyx Pharmaceuticals Inc Financial Overview

Amylyx Pharmaceuticals Inc's market cap is currently $1.82B. The company's EPS TTM is $-1.53; its P/E ratio is -8.65; Amylyx Pharmaceuticals Inc is scheduled to report earnings on March 3, 2026, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 87.37M$ 380.79M$ 22.23M$ 0.00
Gross Profit$ -525.00K$ 45.22M$ 355.35M$ 19.24M$ 0.00
Operating Income$ -153.29M$ -314.73M$ 38.80M$ -201.34M$ -82.69M
EBITDA$ -144.16M$ -290.98M$ 39.89M$ -200.85M$ -82.64M
Net Income$ -144.74M$ -301.74M$ 49.27M$ -198.38M$ -87.93M
Balance Sheet
Cash & Short-Term Investments$ 316.98M$ 176.50M$ 371.36M$ 346.94M$ 96.12M
Total Assets$ 332.64M$ 193.63M$ 517.45M$ 391.45M$ 105.61M
Total Debt$ 5.96M$ 1.98M$ 4.24M$ 6.28M$ 0.00
Net Debt$ -220.69M$ -75.41M$ -165.96M$ -56.25M$ -50.19M
Total Liabilities$ 27.39M$ 28.87M$ 84.02M$ 50.85M$ 256.78M
Stockholders' Equity$ 305.26M$ 164.76M$ 433.43M$ 340.61M$ -151.17M
Cash Flow
Free Cash Flow$ -123.48M$ -167.80M$ 10.68M$ -182.40M$ -75.15M
Operating Cash Flow$ -123.34M$ -167.65M$ 11.92M$ -179.87M$ -74.80M
Investing Cash Flow$ 14.04M$ 75.65M$ 92.05M$ -238.99M$ -46.41M
Financing Cash Flow$ 257.03M$ 348.00K$ 3.54M$ 431.79M$ 158.51M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

Income Statement >

Amylyx Pharmaceuticals Inc Debt to Assets

Balance Sheet >

Amylyx Pharmaceuticals Inc Cash Flow

Cash Flow >

Amylyx Pharmaceuticals Inc Forecast EPS vs Actual EPS

Earnings >